CLINICAL_TRIALS
trial_result
· 2020-07-01
Clinical Trial Update: Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP) [Phase 2]
Summary
Phase 2 trial update for ixekizumab in pityriasis rubra pilaris has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oregon Health and Science University | Conditions: Pityriasis Rubra Pilaris | Phase 2 | Status: COMPLETED | Results posted: 2020-07-01